Nanjing Carephar Shenghui Pharmaceutical Co., Ltd., founded in 2004, is a modern pharmaceutical company dedicated to the innovation, manufacturing, and commercialization of traditional Chinese medicine (TCM), plant-derived healthcare products, and natural active ingredients.

With a focus on therapeutic areas where Chinese medicine demonstrates strong clinical advantages—particularly cardiovascular, cerebrovascular, and respiratory diseases—Carephar Shenghui has developed a diversified healthcare portfolio covering pharmaceutical drugs, botanical health supplements, herbal wellness products, and functional ingredients.

Through continuous technological innovation and pharmaceutical development, the company integrates traditional medical knowledge with modern pharmaceutical science, aiming to deliver safe, effective, and high-quality healthcare solutions to patients and consumers.

Carephar Shenghui maintains long-term collaborations with leading TCM research institutes, universities, and medical institutions in China, supporting the modernization and internationalization of Chinese medicine.

Key Facts

Founded: 2004

Industry: Pharmaceutical & Botanical Healthcare

Core Focus: Cardiovascular, Cerebrovascular, and Respiratory Health

R&D Investment (2020–2023): RMB 150+ million

Patents: 70+ national patents

Scientific Publications: 28 research papers

Product Pipeline: 10+ pharmaceutical and botanical health products

Technology Platforms: Botanical extraction, pharmaceutical formulation, and functional ingredient development

The company has been recognized as a National High-Tech Enterprise, Jiangsu Specialized and Innovative Enterprise, and Gazelle Enterprise, reflecting its strong innovation capabilities and technological growth.

Innovation and Research

Innovation is a core driver of Carephar Shenghui’s development strategy. The company focuses on unmet clinical needs and preventive healthcare, developing innovative products based on the therapeutic advantages of traditional Chinese medicine.

Research areas include:

Innovative patented TCM pharmaceuticals

Improved herbal medicines and dosage forms

Medicinal-food homologous botanical products

Plant-based dietary supplements

Natural bioactive ingredient technologies

Through collaboration with academic institutions and clinical experts, the company continues to advance the modernization and scientific validation of traditional Chinese medicine.

Product Ecosystem

Carephar Shenghui has built a diversified product portfolio spanning pharmaceutical medicines, botanical health products, herbal wellness therapies, and natural functional ingredients.

Innovative Traditional Chinese Medicines

Naomaili Granules

A modern innovative TCM developed from classical herbal formulations. The product is recommended in clinical guidelines for stroke prevention and rehabilitation, offering clear therapeutic mechanisms and proven clinical safety.

Golden Buckwheat Chewable Tablets

An improved botanical medicine designed for respiratory health. The chewable formulation improves convenience and patient compliance and is recommended in integrated Chinese-Western medicine consensus for COPD management.

Botanical Health Supplements

VESU Tongmai Capsules

A plant-derived vascular health supplement formulated with medicinal-food homologous botanical extracts. It supports circulation, improves vascular elasticity, and contributes to overall cardiovascular wellness.

Herbal Wellness Products

The company also develops a wide range of herbal wellness solutions, including:

Herbal Tea Formulas based on traditional medicinal recipes

Herbal Foot Bath Packs formulated for therapeutic relaxation and circulation support

Herbal Plasters and Patches for external therapy and pain relief

Herbal Fumigation Packs based on traditional Chinese herbal therapy

These products combine authentic herbal materials with modern manufacturing standards to support daily wellness and preventive healthcare.

Natural Ingredient Technology

Carephar Shenghui is also actively developing advanced plant-based functional ingredients.

In collaboration with China Agricultural University, the company has developed a proprietary submicron encapsulated curcumin technology, significantly improving the limitations of conventional curcumin.

Key advantages include:

Approximately 8× higher bioavailability compared with conventional curcumin

Improved water solubility and stability

Enhanced antioxidant activity

Stable particle structure with high encapsulation efficiency

This technology enables curcumin to be widely applied in functional foods, dietary supplements, and pharmaceutical formulations.

Vision and Global Strategy

Carephar Shenghui is committed to advancing the modernization, industrialization, and globalization of traditional Chinese medicine.

By integrating traditional herbal wisdom with modern pharmaceutical technologies, the company strives to deliver high-quality healthcare solutions and expand the global influence of Chinese medicine.

With a strong foundation in innovation, product development, and scientific research, Carephar Shenghui aims to become a globally recognized botanical pharmaceutical and healthcare company.